Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: Evidence from the MIST2 randomised controlled trial.

Схожие документы

• Intrapleural use of tissue plasminogen activator and DNase in pleural infection
  по: Rahman, N, и др.
  Опубликовано: (2011)
• Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
  по: Rahman, N, и др.
  Опубликовано: (2011)
• The biological effect of tissue plasminogen (t-PA) activator and DNase intrapleural delivery in pleural infection patients
  по: Kanellakis, N, и др.
  Опубликовано: (2018)
• PRIMARY RESULT OF THE SECOND MULTICENTRE INTRAPLEURAL SEPSIS (MIST2) TRIAL; RANDOMISED TRIAL OF INTRAPLEURAL TPA AND DNASE IN PLEURAL INFECTION
  по: Rahman, N, и др.
  Опубликовано: (2009)
• Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
  по: Kanellakis, N, и др.
  Опубликовано: (2019)